Financhill
Back

ADC Therapeutics SA Stock Predictions

ADC Therapeutics SA Stock Forecast

  • Is ADC Therapeutics SA Stock Undervalued?
    The current ADC Therapeutics SA [ADCT] share price is $2.39. The Score for ADCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ADCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ADC Therapeutics SA Stock Go Up Next Year?

Data Unavailable

ADC Therapeutics SA Stock Rating

Data Unavailable

ADC Therapeutics SA Stock Price History

Is ADCT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adctherapeutics.com

52-Week Data

52-Week High:
6.04
52-Week Low:
0.64

Prediction Charts

Market Cap:
231.09M
Price in USD:
2.39
Volume:
457.73K
Beta:
1.61

Technical Analysis

SMA50:
3.01
SMA100:
3.09
SMA200:
3.65
52-Wk Change:
308.55%

Stock Predictions

  • Is ADC Therapeutics SA stock public?
    Yes, ADC Therapeutics SA is a publicly traded company.
  • What is the ADC Therapeutics SA stock quote today?
    The ADC Therapeutics SA stock price is 2.39 USD today.
  • How to buy ADC Therapeutics SA stock online?
    You can buy ADC Therapeutics SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 3.04 3.01 3.07 2.93
Oct-30 3.03 2.95 3.09 2.93
Oct-31 2.94 2.82 2.95 2.81
Nov-1 2.89 2.95 2.95 2.83
Nov-4 2.96 3.02 3.11 2.86
Nov-5 2.97 3.05 3.09 2.95
Nov-6 3.17 3.20 3.30 3.04
Nov-7 3.21 2.93 3.21 2.81
Nov-8 3.06 2.93 3.07 2.92
Nov-11 2.91 2.98 2.98 2.76
Nov-12 2.95 2.93 2.96 2.78
Nov-13 2.91 2.82 3.06 2.77
Nov-14 2.85 2.65 2.87 2.61
Nov-15 2.68 2.39 2.70 2.32

ADC Therapeutics SA Earnings

Data Unavailable

ADC Therapeutics SA Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.

* ADC Therapeutics SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.